Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00796744 · ClinicalTrials.gov registry record · Phase 2
Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers
A Phase 2 study of Diabetic Foot and Foot Ulcer, Diabetic, sponsored by US Biotest.
- Completed
- Registry status
- Phase 2
- Development phase
- 78
- Enrollment target
- 12
- Study locations
NCT00796744: Completed Phase 2 study of Diabetic Foot and Foot Ulcer, Diabetic, sponsored by US Biotest.
NCT00796744 is a Phase 2 study of Diabetic Foot and Foot Ulcer, Diabetic that has completed, run by US Biotest. The registered enrollment target is 78 participants, below the 10,339-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower). The trial reports 12 study locations across 9 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00796744, a Phase 2 study of Diabetic Foot and Foot Ulcer, Diabetic, has completed, sponsored by US Biotest.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 78 participants
- Enrollment target
- 12
- Study locations
Study Summary
The purpose of this study is to assess if the experimental drug, DSC127, is safe, how well it can be tolerated, and how different doses effect the healing of the chronic foot ulcers in diabetic subjects.
Conditions Studied
Interventions
- DRUG NorLeu3-A(1-7) in a gel formulation
Study Locations (12)
California
- Bay Area Footcare - Castro Valley
- University of California, San Diego - San Diego
- Olive View - UCLA Medical Center - Sylmar
Arizona
- Southern Arizona VA Health Care System - Tucson
- Southern Arizona Limb Salvage Alliance (SALSA) - Tucson
Illinois
- Passavant Area Hospital - Jacksonville
Maryland
- Georgetown University Medical Center - Georgetown
Massachusetts
- Boston University School of Medicine - Boston
North Carolina
- Eastern Carolina Foot & Ankle Specialists - Greenville
Pennsylvania
- Warren General Hospital Wound Clinic - Warren
Texas
- Renaissance Hospital Dallas - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2008-10 |
| Est. Completion | 2011-05 |
| Phase | Phase 2 |
What the finished NCT00796744 record still lists
NCT00796744 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 10,339-participant average among 30 other Diabetic Foot trials with a reported enrollment target (99% lower).
The record links to 2 conditions, with Diabetic Foot appearing as the primary indexed condition, and to 1 intervention - of which NorLeu3-A(1-7) in a gel formulation is the first listed.
NCT00796744 lists 12 locations in 9 states (California, Arizona, Illinois).
Frequently Asked Questions
What is clinical trial NCT00796744 about?
NCT00796744 is a clinical study titled "Safety and Efficacy Study of DSC127 in Treating Subjects With Diabetic Ulcers". The purpose of this study is to assess if the experimental drug, DSC127, is safe, how well it can be tolerated, and how different doses effect the healing of the chronic foot ulcers in diabetic subjects.
What is the current status of trial NCT00796744?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 78 participants. The study started on 2008-10. Estimated completion is 2011-05.
What conditions does trial NCT00796744 study?
This clinical trial studies the following conditions: Diabetic Foot, Foot Ulcer, Diabetic.
What interventions are being tested in trial NCT00796744?
The interventions under investigation include: NorLeu3-A(1-7) in a gel formulation (DRUG).
Who is sponsoring clinical trial NCT00796744?
This trial is sponsored by US Biotest, which has 4 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00796744 being conducted?
This trial has 12 study locations across Arizona, California, Illinois, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00796744's enrollment target sits among peer trials
78 22nd of 30 higher than 9 of 30 other Diabetic Foot trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetic Foot trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Cooling Leg and Foot Ulcer Skin Post Healing to Prevent Ulcer Recurrence
COMPLETED · Phase 2
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
DFC 004 Biomarkers for Active Diabetic Foot Ulcers
RECRUITING
-
Effectiveness of Remote Foot Temperature Monitoring
RECRUITING · NA
-
A Real-World Registry of Chronic Wounds and Ulcers
RECRUITING
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia